Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy

BACKGROUND: Natalizumab is an effective treatment for relapsing multiple sclerosis. Return of disease activity upon natalizumab discontinuance creates the need for follow-up therapeutic strategies. OBJECTIVE: To assess the efficacy of teriflunomide following natalizumab discontinuance in relapsing m...

Full description

Saved in:
Bibliographic Details
Published in:Mult Scler J Exp Transl Clin
Main Authors: Cohan, Stanley L, Edwards, Keith, Lucas, Lindsay, Gervasi-Follmar, Tiffany, O’Connor, Judy, Siuta, Jessica, Kamath, Vineetha, Garten, Lore, Chen, Chiayi, Thomas, James, Smoot, Kyle, Kresa-Reahl, Kiren, Spinelli, Kateri J
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Original Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350141/
https://ncbi.nlm.nih.gov/pubmed/30729028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318824618
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items